impact factor, citescore
logo
 

Full Papers

 

Lung cancer risk in systemic sclerosis: data from an inception cohort and meta-analysis of published studies


1, 2, 3, 4, 5, 6, 7

 

  1. First Propaedeutic and Internal Medicine and Joint Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Greece.
  2. First Propaedeutic and Internal Medicine and Joint Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Greece.
  3. First Propaedeutic and Internal Medicine and Joint Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Greece.
  4. First Propaedeutic and Internal Medicine and Joint Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Greece.
  5. First Propaedeutic and Internal Medicine and Joint Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Greece.
  6. First Propaedeutic and Internal Medicine and Joint Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Greece.
  7. First Propaedeutic and Internal Medicine and Joint Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Greece. sty.panopoulos@gmail.com

CER19647
Full Papers

purchase article

PMID: 42544606 [PubMed]

Received: 31/12/2025
Accepted : 26/03/2026
In Press: 28/07/2026

Abstract

OBJECTIVES:
Population-based cohort studies show an association between systemic sclerosis (SSc) and lung cancer; however, a Mendelian randomisation analysis refutes causality. Herein, lung cancer risk is analysed in an academic inception SSc cohort, complemented by a meta-analysis of published data.
METHODS:
Patients evaluated within 12 months of SSc onset, between January 1995 and December 2020, with regular follow-up until December 2024, were included. Clinical manifestations, laboratory parameters, treatments and comorbidities were prospectively recorded. Age-standardised incidence ratio (SIR) of lung cancer was estimated using the Global Cancer Observatory database. Lung cancer determinants were evaluated with Cox proportional hazards models. A systematic literature search for the association between SSc and cancer and a meta-analysis of lung cancer SIRs from eligible studies was conducted.
RESULTS:
Among 180 patients (2,110 person-years follow-up), lung cancer was diagnosed in 12, after a mean 10.2±5.9 years from SSc onset. Age-SIR was 5.1 (95% CI 4.7-5.4) for the entire cohort, 3.8 (95% CI 3.5-4.1) for male and 9.5 (95% CI 8.7-10.3) for female patients. Diffuse subtype [HR = 4.22, 95% CI: 1.03-17.35] and smoking history [HR = 4.49, 95% CI: 1.14-17.69] were associated with lung cancer development, whereas digital ulcers were inversely associated [HR: 0.13, 95% CI: 0.03–0.63]. The meta-analysis of 17 studies (27,563 SSc patients) yielded a pooled lung cancer age-SIR of 3.85 [95% CI (2.63-5.63)].
CONCLUSIONS:
Long-term follow-up data from an SSc inception cohort indicate a fivefold increased lung cancer risk in SSc, nearly doubled among female patients. Further studies are warranted to inform screening strategies.

DOI: https://doi.org/10.55563/clinexprheumatol/by5ndi

Rheumatology Article

Rheumatology Addendum